title: Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non-Small Cell Lung Cancer Patient.
authors.affiliation: *Thoracic Oncology Section, Gustave Roussy Cancer Campus, Villejuif, France; and †Thoracic Oncology Section, University of Paris-Sud, Villejuif, France.
authors.forename: Jordi
authors.initials: J
authors.lastname: Remon
authors.forename: Anas
authors.initials: A
authors.lastname: Gazzah
authors.forename: Benjamin
authors.initials: B
authors.lastname: Besse
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Soria
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D000077547:Crizotinib; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D010003:Osteoarthritis / Q000150:complications / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D000093542:Gemcitabine
chemical_list: D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D003841:Deoxycytidine; D000077547:Crizotinib; D002945:Cisplatin; D000093542:Gemcitabine